Cultures containing a mixture of B3Z T cell hybrids and DC2.4 APCs (2 × 105 cells/ml each) were plated in 6-well tissue culture plates (X-Gal assays) or 96-well flat-bottom tissue culture plates (ONPG assays), and peptides or bacteria were added. Peptides (listed in Table 2) were synthesized and purchased from GenScript and resuspended in dimethyl sulfoxide (DMSO) at a stock concentration of 20 mg/ml. B. melitensis and variants were used at an MOI of 100. For some assays, APCs were treated with tauroursodeoxycholic acid (TUDCA; Sigma) at 100 μg/ml, or tunicamycin (Sigma) at 10 μg/ml, or mouse IFN-γ (PromoKine) at 1 μg/ml. After overnight incubation, cells were washed in PBS and fixed (X-Gal assay) or lysed (ONPG assay). For X-Gal staining, cells were fixed with 4% paraformaldehyde (PFA) for 10 min, washed 3 timed in PBS, and overlaid with a solution of 1 mg X-Gal/ml, 5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, and 2 mM MgCl2. After an overnight incubation at 37°C, plates were examined microscopically for the presence of blue (lacZ expressing) cells. For ONPG staining, we used a SensoLyte ONPG β-galactosidase assay kit (AnaSpec, Inc.) as per the manufacturer's recommended protocol, except that the incubation at 37°C was overnight. Absorbance reading was at 405 nm.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.